Intellectual Property

  • October 18, 2024

    Fed. Circ. Won't Question Reviving Vascepa Skinny Label Row

    The Federal Circuit has said the full appellate court will not rethink a panel's decision reinstating Vascepa maker Amarin Pharma Inc.'s skinny label patent case against rival U.K. drugmaker Hikma.

  • October 18, 2024

    Teva Signs Deal With Indirect Buyers In Effexor Antitrust Suit

    A class of consumers and third-party payers have reached a deal with Teva Pharmaceuticals to resolve antitrust litigation over a purported scheme to delay generic competition for the antidepressant drug Effexor XR, according to a court filing.

  • October 18, 2024

    Biotech Co. Wins Injunction Against Ex-Worker In Secrets Suit

    Biotech startup Trilobio Inc. won a temporary restraining order against a former employee after a California federal judge concluded the company has a strong likelihood of success on its claims that the worker stole trade secrets to start his own business after being fired for poor performance.

  • October 18, 2024

    Dick's Sporting Goods Escapes NY Apparel Co.'s $8M TM Suit

    A New York-based sports apparel company has dropped its $8 million federal lawsuit accusing Dick's Sporting Goods of infringing its registered logo featuring an infinity symbol.

  • October 18, 2024

    Skiplagged Must Pay American Airlines $9.4M In IP Row

    American Airlines came out on top in a suit against airfare search engine Skiplagged Inc., with a jury finding that Skiplagged must cough up $9.4 million for infringing the airline's copyright. 

  • October 18, 2024

    SunPower Corp. Gets OK For Chapter 11 Plan

    A Delaware bankruptcy judge Friday approved residential solar technology company SunPower Corp.'s plans to distribute the proceeds of its asset sales to the creditors in its Chapter 11 case after hearing all objections had been resolved or put off.

  • October 18, 2024

    Justices Told To Skip RFID Patent Row Over Standing

    A Texas company that saw its patent infringement suit revived against a tech company is asking the U.S. Supreme Court to reject its rival's petition to review that decision, saying there's "almost 100 years" of legal precedent backing its ownership of the radio frequency identification, or RFID, technology patent in the case.

  • October 18, 2024

    Google Play Store Injunction Paused To Let 9th Circ. Weigh In

    A California federal judge on Friday briefly paused his injunction requiring Google to open up its Play Store to competition while the tech giant seeks an emergency stay of the injunction at the Ninth Circuit, where it's appealing a jury verdict that it illegally monopolized the Android app distribution and payment market.

  • October 18, 2024

    Fed. Circ. Partly Restores Suit Over Utility Line Patent

    The Federal Circuit has revived part of a lawsuit that alleged Metrotech Corp. infringed a competitor's patent covering ways for finding underground utility lines, finding that a lower court needs to take another look at key patent terminology.

  • October 18, 2024

    Off The Bench: Wemby Suit, Antitrust Fights In NASCAR, MMA

    In this week's Off The Bench, NBA superstar Victor Wembanyama sues over illicit merchandise bearing his likeness, while antitrust litigation rocks NASCAR and mixed martial arts promotion Bellator.

  • October 18, 2024

    Western Digital Hit With $315.7M Verdict In Patent Suit

    Western Digital must pay SPEX Technologies nearly $316 million in damages for infringing its patent related to hardware encryption technology in Western Digital's Ultrastar and My Book data storage devices, a California federal jury decided on Friday.

  • October 18, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen Professor Cat Jarman, Earl Spencer's new girlfriend, sue his ex-wife, Bitcoin fraudster Craig Wright file a £911 billion ($1.18 trillion) claim against BTC Core, journalist Oliver Kamm hit novelist Ros Barber with a defamation claim, and a barrister at Cloisters face a claim from a former client. Here, Law360 looks at these and other new claims in the U.K.

  • October 18, 2024

    NCAA's $2.78B NIL Deal Still Faces Long Road To Final OK

    The absence of noticeable change to address concerns flagged by a California federal judge about the NCAA's $2.78 billion name, image and likeness compensation settlement made that same judge's preliminary approval of the deal last week surprising, and experts say those same problematic provisions likely will make final approval an uphill battle.

  • October 17, 2024

    OnePlus Owes Pantech $1M After Patent Verdict Do-Over

    A Texas federal jury Thursday determined that Chinese phone company OnePlus owes Pantech Corp. almost $1 million in damages for infringing four patents related to technology used to comply with 5G wireless standards, after the initial $10 million verdict was tossed as "excessive."

  • October 17, 2024

    'More Honesty' Needed In Philips IP Row, Judge Says

    A Texas federal judge told the owner of a company accused of pilfering around $12 million worth of Philips North America LLC's trade secrets that things might have gone better if he had "been more honest," pointing out that he had given contradictory testimony during a hearing Thursday.

  • October 17, 2024

    VLSI To Del. Judge: 'There Is Nothing Else To Disclose'

    VLSI Technology LLC has fully complied with its disclosure requirements for ownership and litigation funding, and Intel Corp.'s claims otherwise in patent licensing litigation don't hold up, VLSI told a Delaware federal judge.

  • October 17, 2024

    Temu Says Shein Launched IP Theft Suit To Stifle Competition

    The companies behind e-commerce platform Temu have fired back at fast fashion company Shein's intellectual property infringement claims against them, accusing Shein of filing a meritless suit to interfere with Temu's business and stifle its competition "by any means possible."

  • October 17, 2024

    USPTO Told More Clarity Needed On AI And Patent Eligibility

    Numerous companies and industry groups have said they welcome the U.S. Patent and Trademark Office's new guidance on when inventions involving artificial intelligence are eligible for patents, but many urged the agency to provide additional clarity and practical examples.

  • October 17, 2024

    Microsoft Fights IP, Antitrust Suit Alleging Cartel With Nvidia

    Microsoft slammed a lawsuit brought by a startup accusing it, Nvidia and a third company of engaging in patent infringement and an illegal buyers' cartel suppressing the price of graphic processing units used in powering artificial intelligence, urging a Texas federal judge Wednesday to deny an injunction bid due to lack of evidence.

  • October 17, 2024

    How Muhammad Ali's Ex-Photog Won $2.7M From Brand Co.

    When Muhammad Ali's former personal photographer brought a copyright suit against a powerful brand management company, his attorneys faced a daunting challenge at trial: How can they convince jurors that Authentic Brands Group was liable for willful infringement?

  • October 17, 2024

    Gov't Tells Justices To Reject Return Mail's Alice Petition

    The federal government says the U.S. Supreme Court should not hear a small Alabama company's appeal of a lower court's invalidation of claims in its patent on processing undeliverable mail, arguing that the claims were not patent eligible.

  • October 17, 2024

    Hospital Can Use TM Fraud Claim As Shield, Not Sword

    A North Carolina hospital and healthcare provider can't pursue a trademark fraud counterclaim in a weight loss clinic's infringement dispute but can assert the claim as an affirmative defense, a federal judge ruled.

  • October 17, 2024

    Justices Urged To Fix 'Novel Misreading' Of IP Safe Harbor

    Edwards Lifesciences is asking the U.S. Supreme Court to rein in what's covered under a drug-development safe harbor to avoid patent infringement, saying the Federal Circuit wrongfully expanded it in a "novel misreading" of the law.

  • October 17, 2024

    Cisco Foe Takes Computer Security Patent Feud To Fed. Circ.

    A cybersecurity startup that saw its multibillion-dollar patent win against Cisco erased is pinning the failure, in part, on a new judge's "eleventh-hour, sua sponte claim construction" and is asking the Federal Circuit to overturn it.

  • October 17, 2024

    Northwestern Hits Moderna With Patent Suit Over COVID Vax

    Northwestern University has launched a patent infringement lawsuit in Delaware federal court accusing Moderna of wrongly taking research that the school did when the company was making its COVID-19 vaccine.

Expert Analysis

  • Roundup

    After Chevron

    Author Photo

    Since the U.S. Supreme Court overturned the Chevron deference standard in June, this Expert Analysis series has featured attorneys discussing the potential impact across 36 different rulemaking and litigation areas.

  • How Life Science Companies Are Approaching UPC Opt-Outs

    Author Photo

    A look at recent data shows that one year after its launch, the European Union's Unified Patent Court is still seeing a high rate of opt-outs, including from large U.S.-based life science companies wary of this unpredictable court — and there are reasons this strategy should largely remain the same, say Sanjay Murthy and Christopher Tuinenga at McAndrews Held.

  • Series

    After Chevron: Expect Few Changes In ITC Rulemaking

    Author Photo

    The U.S. Supreme Court's opinion overruling the Chevron doctrine will have less impact on the U.S. International Trade Commission than other agencies administering trade statutes, given that the commission exercises its congressionally granted authority in a manner that allows for consistent decision making at both agency and judicial levels, say attorneys at Polsinelli.

  • 6 PTAB Events To Know From The Last 6 Months

    Author Photo

    The first half of 2024 brought a flurry of Patent Trial and Appeal Board developments that should be considered in post-grant strategies, including proposed rules on discretionary denial and director review, and the first decisions of the Delegated Rehearing Panel, say attorneys at Fish & Richardson.

  • Opinion

    Atty Well-Being Efforts Ignore Root Causes Of The Problem

    Author Photo

    The legal industry is engaged in a critical conversation about lawyers' mental health, but current attorney well-being programs primarily focus on helping lawyers cope with the stress of excessive workloads, instead of examining whether this work culture is even fundamentally compatible with lawyer well-being, says Jonathan Baum at Avenir Guild.

  • FTC Focus: Competition And The Right To Repair

    Author Photo

    If the Federal Trade Commission includes commercial and industrial products as part of copyright exemptions that allow consumers to modify or repair products, then businesses and affected rights holders will need to consider copyrights' impact on infringement issues, say attorneys at Proskauer.

  • The Fed. Circ. In May: A Major Shift In Design Patent Law

    Author Photo

    The Federal Circuit's recent en banc decision in LKQ v. GM overruled three decades of precedent and adopted a new standard for assessing the obviousness of design patents, leaving many questions unanswered, say Sean Murray and Jeremiah Helm at Knobbe Martens.

  • Series

    Skiing And Surfing Make Me A Better Lawyer

    Author Photo

    The skills I’ve learned while riding waves in the ocean and slopes in the mountains have translated to my legal career — developing strong mentor relationships, remaining calm in difficult situations, and being prepared and able to move to a backup plan when needed, says Brian Claassen at Knobbe Martens.

  • Unpacking The Circuit Split Over A Federal Atty Fee Rule

    Author Photo

    Federal circuit courts that have addressed Rule 41(d) of the Federal Rules of Civil Procedure are split as to whether attorney fees are included as part of the costs of a previously dismissed action, so practitioners aiming to recover or avoid fees should tailor arguments to the appropriate court, says Joseph Myles and Lionel Lavenue at Finnegan.

  • 4 Steps To Repair Defense Credibility In Opening Statements

    Author Photo

    Given the continued rise of record-breaking verdicts, defense counsel need to consider fresh approaches to counteract the factors coloring juror attitudes — starting with a formula for rebuilding credibility at the very beginning of opening statements, says Ken Broda-Bahm at Persuasion Strategies.

  • Fair Use Doctrine Faces Challenges In The Generative AI Era

    Author Photo

    As courts struggle to apply existing copyright principles to new, digital contexts, the evolving capabilities of AI technologies are testing the limits of traditional frameworks, with the fair use doctrine being met with significant challenges, says John Poulos at Norton Rose.

  • Prejudicial Evidence Takeaways From Trump Hush Money Trial

    Author Photo

    The Manhattan District Attorney's Office's prosecution and conviction of former President Donald Trump on 34 felony counts provides a lesson on whether evidence may cause substantial unfair prejudice, or if its prejudicial potential is perfectly fair within the bounds of the law, says Reuben Guttman at Guttman Buschner.

  • Opinion

    Why The Patent Eligibility Restoration Act Can Spur Progress

    Author Photo

    Patent practitioners have long wrestled with the effects of U.S. Supreme Court decisions that have muddied the waters of what can be patented, but the Patent Eligibility Restoration Act can change that, and those not involved with patents on a day-to-day basis can help get this act passed, says John White at Harness IP.

  • After A Brief Hiccup, The 'Rocket Docket' Soars Back To No. 1

    Author Photo

    The Eastern District of Virginia’s precipitous 2022 fall from its storied rocket docket status appears to have been a temporary aberration, as recent statistics reveal that the court is once again back on top as the fastest federal civil trial court in the nation, says Robert Tata at Hunton.

  • Protecting Trade Secrets In US, EU Gov't Agency Submissions

    Author Photo

    Attorneys at Mintz compare U.S. and European Union trade secret laws, and how proprietary information in confidential submissions to the U.S. Food and Drug Administration and the European Medicines Agency is protected in the face of third-party information requests under government transparency laws.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!